D. Beattie

发表

The pharmacology of GR203040, a novel, potent and selective non‐peptide tachykinin NK1 receptor antagonist

R. Hagan, F. Marshall, I. Beresford, 1995, British journal of pharmacology.

GR127935: a potent and selective 5-HT1D receptor antagonist

S. J. Starkey, W. Feniuk, M. Skingle, 1995, Behavioural Brain Research.

D. Saynor, W. Feniuk, H. Connor, 1997, Reactions weekly.

Central & Peripheral Nervous Systems The evolution of selective 5-HT1 D receptor antagonists

M. Skingle, Dic Scopes, D. Beattie, 1995 .

The influence of the trigeminal ganglion on carotid blood flow in anaesthetized guinea‐pigs

H. Connor, D. Beattie, 1994, British journal of pharmacology.

Neurokinin‐induced changes in pial artery diameter in the anaesthetized guinea‐pig

W. Feniuk, D. Beattie, H. Connor, 1993, British journal of pharmacology.

Section Review—Central & Peripheral Nervous Systems: The Evolution of Selective 5-HTID Receptor Antagonists

M. Skingle, Dic Scopes, D. Beattie, 1995 .

Evolution of a Novel Series of ((N,N-Dimethylamino)propyl)- and Piperazinylbenzanilides as the First Selective 5-HT1D Antagonists.

G. Higgins, D. Scopes, A. Oxford, 1994 .

Serotonin pharmacology in the gastrointestinal tract: a review

J. A. Smith, D. Beattie, D. Beattie, 2008, Naunyn-Schmiedeberg's Archives of Pharmacology.

Clinical trial: the efficacy and tolerability of velusetrag, a selective 5‐HT4 agonist with high intrinsic activity, in chronic idiopathic constipation – a 4‐week, randomized, double‐blind, placebo‐controlled, dose–response study

J. Johanson, M. Goldberg, O. Daniels, 2010, Alimentary pharmacology & therapeutics.